BioSpace News Archive

Financing provides support for NDA filing of KPI-121 0.25%, INVELTYS launch, and topline results for the STRIDE-3 trial of KPI-121 0.25%

Kala Pharmaceuticals, Inc. announced today that it has commenced an underwritten public offering of 7,500,000 shares of its common stock.

the UK’s national centre for commercialisation of synthetic biology, is pleased to announce the launch of a new five-year strategy underpinned by a new £5M grant from UKRI and other sources.

CRF Health, a CRF Bracket company, the leading provider of patient-centered eSource technology solutions for the life sciences industry, today unveiled details of its 2018 eCOA Forum.

Osiris Therapeutics, Inc. announced today that a new peer-reviewed manuscript entitled “Properties of Viable Lyopreserved Amnion Are Equivalent to Viable Cryopreserved Amnion with the Convenience of Ambient Storage” has been published in PLOS ONE and is available online https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0204060.

CardioVascular BioTherapeutics, Inc. is pleased to welcome Ori Ben-Yehuda, MD, FACC as our new Chief Medical Officer (CMO). “Dr. Ben-Yehuda brings leading edge skills and demonstrated drug development success to the Company.

Pain Therapeutics, Inc. today announced that it will host a live conference call to provide a strategic update regarding its business, its science and its pipeline.

CytoSen Therapeutics and KBI Biopharma today announced a strategic partnership to manufacture therapeutic Natural Killer (NK) cells using a proprietary and scalable, closed system manufacturing process.

On Wednesday, October 10, Kennedy Krieger Institute will salute pioneering news anchor Judy Woodruff, whose experience supporting her eldest son after a traumatic brain injury inspired her to shine a spotlight on pediatric brain disorders while advocating for the future of care.

Telix Pharmaceuticals (US) Inc. today announced that it has entered into a distribution agreement with Cardinal Health (NYSE:CAH).